Naturhouse Health, S.A. (NTH.MC)
EUR 1.69
(0.0%)
EUR 1.69
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 17.93 Million EUR | 18.93% |
| 2022 | 15.29 Million EUR | -25.75% |
| 2021 | 20.21 Million EUR | 16.05% |
| 2020 | 16.66 Million EUR | -22.29% |
| 2019 | 23.54 Million EUR | -2.13% |
| 2018 | 23.3 Million EUR | -20.06% |
| 2017 | 29.41 Million EUR | -11.01% |
| 2016 | 32.39 Million EUR | -3.67% |
| 2015 | 33.63 Million EUR | -0.6% |
| 2014 | 34.92 Million EUR | 127.45% |
| 2013 | 13.81 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 4.23 Million EUR | 36.13% |
| 2024 Q2 | 4.23 Million EUR | 0.0% |
| 2023 Q1 | - EUR | 0.0% |
| 2023 Q2 | - EUR | 0.0% |
| 2023 Q3 | 3.11 Million EUR | 0.0% |
| 2023 Q4 | 3.11 Million EUR | 0.0% |
| 2023 FY | - EUR | 18.93% |
| 2022 Q3 | - EUR | 0.0% |
| 2022 Q4 | - EUR | 0.0% |
| 2022 Q1 | 9.16 Million EUR | 0.0% |
| 2022 FY | - EUR | -25.75% |
| 2021 Q1 | 5.56 Million EUR | 49.97% |
| 2021 Q2 | 6.8 Million EUR | 22.2% |
| 2021 FY | - EUR | 16.05% |
| 2020 Q1 | 4.18 Million EUR | -11.59% |
| 2020 Q3 | 6.35 Million EUR | 106.24% |
| 2020 Q4 | 3.71 Million EUR | -41.54% |
| 2020 Q2 | 3.07 Million EUR | -26.37% |
| 2020 FY | - EUR | -22.29% |
| 2019 Q1 | 6.31 Million EUR | 61.77% |
| 2019 FY | - EUR | -2.13% |
| 2019 Q2 | 7.91 Million EUR | 25.28% |
| 2019 Q4 | 4.73 Million EUR | -2.11% |
| 2019 Q3 | 4.83 Million EUR | -38.91% |
| 2018 Q3 | 3.79 Million EUR | -59.48% |
| 2018 FY | - EUR | -20.06% |
| 2018 Q4 | 3.9 Million EUR | 2.9% |
| 2018 Q1 | 6.84 Million EUR | 59.4% |
| 2018 Q2 | 9.36 Million EUR | 36.86% |
| 2017 Q1 | 8.5 Million EUR | 35.97% |
| 2017 FY | - EUR | -11.01% |
| 2017 Q4 | 4.29 Million EUR | -29.52% |
| 2017 Q3 | 6.08 Million EUR | -44.22% |
| 2017 Q2 | 10.91 Million EUR | 28.34% |
| 2016 Q1 | 9.04 Million EUR | 19.77% |
| 2016 Q2 | 11.07 Million EUR | 22.4% |
| 2016 Q3 | 7.13 Million EUR | -35.57% |
| 2016 Q4 | 6.25 Million EUR | -12.3% |
| 2016 FY | - EUR | -3.67% |
| 2015 FY | - EUR | -0.6% |
| 2015 Q4 | 7.55 Million EUR | -1.16% |
| 2015 Q3 | 7.64 Million EUR | -29.38% |
| 2015 Q2 | 10.81 Million EUR | 26.57% |
| 2015 Q1 | 8.54 Million EUR | 6.02% |
| 2014 Q2 | 11.2 Million EUR | 41.59% |
| 2014 Q3 | 7.74 Million EUR | -30.91% |
| 2014 FY | - EUR | 127.45% |
| 2014 Q1 | 7.91 Million EUR | 0.0% |
| 2014 Q4 | 8.06 Million EUR | 4.15% |
| 2013 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Ebro Foods, S.A. | 461.21 Million EUR | 96.111% |
| Deoleo, S.A. | -4.01 Million EUR | 546.589% |